Experimental cholesterol drugs cut heart risk, but questions remain

San Diego, March 15 (Reuters) - Studies of a new class of experimental cholesterol-lowering drugs signal that they may reduce by half the risk of heart attack and other major cardiovascular problems compared to standard treatment alone.